Application 220295

Type
NDA
Sponsor
GLAXOSMITHKLINE

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001LYNAVOYLINERIXIBATTABLET;ORAL40MGYesYes

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
85895ORIG 2026-05-13
85477ORIG 2026-03-24
85397ORIG 2026-03-19